Results 191 to 200 of about 6,410,935 (343)

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

Molecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche, Niels J. van Ruitenbeek, Charlotte Adang, Luke O'Gorman, Pui Yuen Lee, Willemijn M. Klein, Adriana C. H. van Engen‐van Grunsven, Jack A. Schalken, Sander Bervoets, Gerald W. Verhaegh, Carla M. L. van Herpen   +10 more
wiley   +1 more source

Discovery of Quercetin as a Potential Entry Inhibitor of Nipah Virus: A Path Toward Antiviral Therapy. [PDF]

Int J Mol Sci
Alam MM, Rahman MM, Raj KH, Nahid AH, Saha P, Hossain A, Amaya M, Laing ED, Satter SM, Broder CC, Hossain ME, Rahman MZ.   +11 more
europepmc   +1 more source

Antiviral efficacy of selective estrogen receptor modulators against SARS-CoV-2 infection in vitro and in vivo reveals bazedoxifene acetate as an entry inhibitor. [PDF]

J Med Virol, 2022
Miao G, Peng H, Tang H, Liu Y, Zheng X, Liu B, Jiang L, Tang W, He Y, Liu Y, Ren H, Zhao P, Qi Z, Ding C.   +13 more
europepmc   +1 more source

Other Titles: Biennial Report of the Kansas State Port of Entry Board, 1960-1972 State Port of Entry Board (1960-1964) Kansas Port of Entry Board (1966-1972)

, 1960
These biennial reports are summaries of the activities of this agency. They were extracted from a series of Kansas agency reports covering over 100 state agencies and institutions bound together for each biennium., 1959/1960 - 1979/1980.
Kansas. Port of Entry Board.
core  

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

Molecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi, Tuan Khang Huynh, Adway Kadam, Zahra Kardan, Yue Yan, Amina Jamal Laham, Sampath Kumar Loganathan   +6 more
wiley   +1 more source

Preclinical Toxicological evaluation of the HIV entry inhibitor peptide 2P23 as a candidate rectovaginal microbicide. [PDF]

Sci Rep
Gao ZQ, Fu R.
europepmc   +1 more source

Ohio guidelines for quality entry year programs

, 2002
Cover title.; "Based on the work of Ohio's Entry Year Advisory Council. Performed under The Title II Teacher Quality Initiative."; "May 2002.

core  

Partial FAK suppression promotes tumor growth, an effect reversed by macrophage p110δ PI3K inactivation

Molecular Oncology, EarlyView.
Partial inhibition of focal adhesion kinase (FAK) can paradoxically promote tumor growth, rather than simply producing a weaker antitumor effect than that observed with strong FAK suppression. In breast cancer and melanoma models, targeting p110δ PI3K, particularly in macrophages, counteracted these tumor‐promoting effects, highlighting the importance ...
Lydia Xenou, Niki Tzenaki, Anna Tsapara, Maria Tzardi, Evangelia A. Papakonstanti   +4 more
wiley   +1 more source

A novel entry inhibitor targeting the stalk domain of the hemagglutinin of H1N1. [PDF]

Acta Pharm Sin B
Gong Y, Bi T, Xiao F, Xu D, Zhang X, Wang H, Yu P, Yang X, Zuo J, Yang L, Yang W, Tong X.   +11 more
europepmc   +1 more source

First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B.

Journal of Hepatology, 2016
A. Blank, Christoph Markert, N. Hohmann, A. Carls, G. Mikus, T. Lehr, A. Alexandrov, M. Haag, M. Schwab, S. Urban, W. Haefeli   +10 more
semanticscholar   +1 more source